Search Results - "RIVARD, G"

Refine Results
  1. 1

    Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada by KRAFT, J., BLANCHETTE, V., BABYN, P., FELDMAN, B., CLOUTIER, S., ISRAELS, S., PAI, M., RIVARD, G.‐E., GOMER, S., McLIMONT, M., MOINEDDIN, R., DORIA, A. S.

    Published in Journal of thrombosis and haemostasis (01-12-2012)
    “…Background/objectives: Tailored primary prophylaxis (TPP) is a reduced‐intensity treatment program for hemophiliacs with the goal of preventing arthropathy…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis by INFANTE-RIVARD, C., RIVARD, G.-E., DEROME, F., CUSSON, A., WINIKOFF, R., CHARTRAND, R., GUAY, J.-P.

    “…Radiosynoviorthesis (RS) is an intra‐articular injection of a radioactive colloid for the treatment of synovitis administered most often to patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies by Ruskey, J.A., Zhou, S., Santiago, R., Franche, L.‐A., Alam, A., Roncière, L., Spiegelman, D., Fon, E.A., Trempe, J.‐F., Kalia, L.V., Postuma, R.B., Dupre, N., Rivard, G.‐E., Assouline, S., Amato, D., Gan‐Or, Z.

    Published in Clinical genetics (01-10-2018)
    “…Biallelic GBA mutations cause Gaucher disease (GD), and heterozygous carriers are at risk for synucleinopathies. No founder GBA mutations in French‐Canadians…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Incidence of hypotension and acute hypotensive transfusion reactions following platelet concentrate transfusions by Du Pont-Thibodeau, G., Robitaille, N., Gauvin, F., Thibault, L., Rivard, G.-É., Lacroix, J., Tucci, M.

    Published in Vox sanguinis (01-02-2016)
    “…Background and objectives Platelet concentrates (PCs) are associated with transfusion reactions involving hypotension, particularly bradykinin‐mediated acute…”
    Get full text
    Journal Article
  8. 8

    Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond by FORSYTH, A. L., RIVARD, G.-É., VALENTINO, L. A., ZOURIKIAN, N., HOFFMAN, M., MONAHAN, P. E., VAN MEEGEREN, M. E. R., FORRIOL, F.

    “…Blood in the joint causes a number of physiological and pathological events that eventually lead to haemophilic arthropathy. Animal models show that blood in…”
    Get full text
    Journal Article
  9. 9

    Epidemiological and Clinical Features of Brucellosis in the Country of Georgia by Akhvlediani, Tamar, Bautista, Christian T, Garuchava, Natalia, Sanodze, Lia, Kokaia, Nora, Malania, Lile, Chitadze, Nazibrola, Sidamonidze, Ketevan, Rivard, Robert G, Hepburn, Matthew J, Nikolich, Mikeljon P, Imnadze, Paata, Trapaidze, Nino

    Published in PloS one (20-01-2017)
    “…Brucellosis is an endemic disease in the country of Georgia. According to the National Center for Disease Control and Public Health of Georgia (NCDC), the…”
    Get full text
    Journal Article
  10. 10

    Standardization of thromboelastography: a report from the TEG-ROTEM working group by CHITLUR, M., SORENSEN, B., RIVARD, G. E., YOUNG, G., INGERSLEV, J., OTHMAN, M., NUGENT, D., KENET, G., ESCOBAR, M., LUSHER, J.

    “…Laboratory evaluation of bleeding disorders has been performed with the standard clotting assays such as the PT and PTT for several decades. Our improved…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Solidification mechanisms of chitosan–glycerol phosphate/blood implant for articular cartilage repair by Marchand, C, Rivard, G.-E, Sun, J, Hoemann, C.D

    Published in Osteoarthritis and cartilage (01-07-2009)
    “…Summary Objective Chitosan–glycerol phosphate (chitosan-GP) is a unique polymer solution that is mixed with whole blood and solidified over microfractured or…”
    Get full text
    Journal Article
  13. 13

    International workshop on immune tolerance induction: consensus recommendations by DIMICHELE, D. M., HOOTS, W. K., PIPE, S. W., RIVARD, G. E., SANTAGOSTINO, E.

    “…Although immune tolerance induction (ITI) has been used for 30 years to eliminate inhibitors and restore normal factor pharmacokinetics in patients with…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds by Andersson, Nadine G, Chalmers, Elizabeth A, Kenet, Gili, Ljung, Rolf, Mäkipernaa, Anne, Chambost, Hervé

    Published in Haematologica (Roma) (01-10-2019)
    “…The optimal mode of delivery for a pregnant hemophilia carrier is still a matter of debate. The aim of the study was to determine the incidence of intracranial…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Vaccinations are not associated with inhibitor development in boys with severe haemophilia A by Platokouki, H., Fischer, K., Gouw, S. C., Rafowicz, A., Carcao, M., Kenet, G., Liesner, R., Kurnik, K., Rivard, G. E., van den Berg, H. M.

    “…Background Inhibitor development in previously untreated patients (PUPs) with severe haemophilia A is a multifactorial event. It is unknown whether paediatric…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography by RIVARD, G. E., BRUMMEL‐ZIEDINS, K. E., MANN, K. G., FAN, L., HOFER, A., COHEN, E.

    Published in Journal of thrombosis and haemostasis (01-09-2005)
    “…The objective of this study was to evaluate the possibility of linking the tracing of whole blood clotting in a thrombelastograph® (TEG®) hemostasis system…”
    Get full text
    Journal Article
  20. 20

    Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study by FELDMAN, B. M., PAI, M., RIVARD, G. E., ISRAELS, S., POON, M.‐C., DEMERS, C., ROBINSON, S., LUKE, K.‐H., WU, J. K. M., GILL, K., LILLICRAP, D., BABYN, P., MCLIMONT, M., BLANCHETTE, V. S.

    Published in Journal of thrombosis and haemostasis (01-06-2006)
    “…Background: Prophylactic treatment for severe hemophilia A is likely to be more effective than treatment when bleeding occurs, however, prophylaxis is costly…”
    Get full text
    Journal Article